Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)
Hepatitis C and polycythemia vera (PV) co-existence is not rare; it has been reported in the literature. Treatment with interferon (IFN) has been used to treat both conditions; however, the use of IFN in concomitant hepatitis C infection with PV and its outcome are rarely described in the literature...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-06-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/515782 |
_version_ | 1819204293656313856 |
---|---|
author | Hawraa Shwaylia Elrazi Ali Mohamed A. Yassin |
author_facet | Hawraa Shwaylia Elrazi Ali Mohamed A. Yassin |
author_sort | Hawraa Shwaylia |
collection | DOAJ |
description | Hepatitis C and polycythemia vera (PV) co-existence is not rare; it has been reported in the literature. Treatment with interferon (IFN) has been used to treat both conditions; however, the use of IFN in concomitant hepatitis C infection with PV and its outcome are rarely described in the literature. Here, we report a 56-years-old male patient with hepatitis C virus infection and PV, who was treated with IFN for his chronic hepatitis C, which resulted in significant improvement of HB as well as normalization of his bone marrow and eradication of the clone (Jak2 V617F). |
first_indexed | 2024-12-23T04:33:31Z |
format | Article |
id | doaj.art-275f84ddf89a47b59551ac8183df5733 |
institution | Directory Open Access Journal |
issn | 1662-6575 |
language | English |
last_indexed | 2024-12-23T04:33:31Z |
publishDate | 2021-06-01 |
publisher | Karger Publishers |
record_format | Article |
series | Case Reports in Oncology |
spelling | doaj.art-275f84ddf89a47b59551ac8183df57332022-12-21T17:59:58ZengKarger PublishersCase Reports in Oncology1662-65752021-06-0114284584810.1159/000515782515782Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)Hawraa Shwaylia0Elrazi Ali1Mohamed A. Yassin2Department of Medical Oncology, Hamad Medical Corporation, Doha, QatarInternal Medicine Department, Hamad Medical Corporation, Doha, QatarDepartment of Medical Oncology, Hamad Medical Corporation, Doha, QatarHepatitis C and polycythemia vera (PV) co-existence is not rare; it has been reported in the literature. Treatment with interferon (IFN) has been used to treat both conditions; however, the use of IFN in concomitant hepatitis C infection with PV and its outcome are rarely described in the literature. Here, we report a 56-years-old male patient with hepatitis C virus infection and PV, who was treated with IFN for his chronic hepatitis C, which resulted in significant improvement of HB as well as normalization of his bone marrow and eradication of the clone (Jak2 V617F).https://www.karger.com/Article/FullText/515782polycythemia verahepatitis chepatitisinterferon |
spellingShingle | Hawraa Shwaylia Elrazi Ali Mohamed A. Yassin Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera) Case Reports in Oncology polycythemia vera hepatitis c hepatitis interferon |
title | Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera) |
title_full | Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera) |
title_fullStr | Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera) |
title_full_unstemmed | Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera) |
title_short | Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera) |
title_sort | interferon alpha 2 a and its dual effect in treating two diseases hepatitis c and polycythemia vera |
topic | polycythemia vera hepatitis c hepatitis interferon |
url | https://www.karger.com/Article/FullText/515782 |
work_keys_str_mv | AT hawraashwaylia interferonalpha2aanditsdualeffectintreatingtwodiseaseshepatitiscandpolycythemiavera AT elraziali interferonalpha2aanditsdualeffectintreatingtwodiseaseshepatitiscandpolycythemiavera AT mohamedayassin interferonalpha2aanditsdualeffectintreatingtwodiseaseshepatitiscandpolycythemiavera |